SQUAMOUS CELL CARCINOMA OF THE BLADDER
Clinical trials for SQUAMOUS CELL CARCINOMA OF THE BLADDER explained in plain language.
Never miss a new study
Get alerted when new SQUAMOUS CELL CARCINOMA OF THE BLADDER trials appear
Sign up with your email to follow new studies for SQUAMOUS CELL CARCINOMA OF THE BLADDER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for rare cancers: drug cocktail targets tough tumors
Disease control Recruiting nowThis study tests whether a combination of two cancer drugs—sacituzumab govitecan and atezolizumab—can shrink or control rare tumors of the bladder, kidney, ureters, and penis. About 60 adults with advanced or spreading cancers will receive the drugs through an IV. The goal is to …
Matched conditions: SQUAMOUS CELL CARCINOMA OF THE BLADDER
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 12:10 UTC
-
Promising drug combo targets rare urinary and testicular cancers
Disease control Recruiting nowThis study tests whether a drug combination already approved for common bladder cancers can help people with rare cancers of the bladder, urinary tract, or testicles. About 68 adults will receive enfortumab vedotin alone or with pembrolizumab. The goal is to shrink tumors and con…
Matched conditions: SQUAMOUS CELL CARCINOMA OF THE BLADDER
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 12:03 UTC